drugset / Trial / NCT02125266
Safety and Preliminary Efficacy Study of V404 PDS in Uveitis
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is intended to evaluate the safety of V404 PDS in patients with chronic non-infectious uveitis. Secondarily, the study will evaluate whether V404 PDS can provide clinically measurable benefit over an extended period of time in patients with chronic non-infectious uveitis.
Timeline
- Start
- 2014-04
- Primary completion
- 2014-10
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | 0.6 mg | Intravitreal |
| Subject | Methotrexate | Small molecule | 2.3 mg | Intravitreal |